BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shan M, Shen Z, Sun H, Zheng J, Zhang M. The enrichment of HBV immune-escape mutations during nucleoside/nucleotide analogue therapy. Antivir Ther. 2017;22:717-720. [PMID: 28300730 DOI: 10.3851/imp3156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang BX, Liu Y, Fan ZP, Si LL, Chen RJ, Wang J, Luo D, Wang FS, Xu DP, Liu XG. Investigation of immune escape-associated mutations of hepatitis B virus in patients harboring hepatitis B virus drug-resistance mutations. World J Gastroenterol 2020; 26(35): 5314-5327 [PMID: 32994690 DOI: 10.3748/wjg.v26.i35.5314] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Park S, Park ES, Koo JE, Park YK, Lee AR, Dezhbord M, Cho ES, Ahn SH, Kim DH, Lee JH, Lee HC, Kim KH. Entecavir-resistant hepatitis B virus decreases surface antigenicity: A full genome and functional characterization. Liver Int 2020;40:1564-77. [PMID: 32216026 DOI: 10.1111/liv.14446] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Takahashi H, Kanda T, Matsumoto N, Shibata T, Nirei K, Tamura A, Matsuoka S, Kuroda K, Moriyama M. Analysis of full-length hepatitis B virus genome from chronic hepatitis B-patients with higher alanine aminotransferase elevation. Future Virology 2020;15:429-39. [DOI: 10.2217/fvl-2020-0104] [Reference Citation Analysis]